Oral positive expiratory pressure device
AssigneePEP Buddy, LLC
InventorsMuhammad Ahsan Zafar, Ralph J. Panos
Life of this patent
Estimating the term…
Loading patent…
AssigneePEP Buddy, LLC
InventorsMuhammad Ahsan Zafar, Ralph J. Panos
Estimating the term…
A compact, hands-free, oral positive expiratory pressure (PEP) device designed to optimize respiratory mechanics by providing controlled resistance during exhalation. The device slows the respiratory rate, prolongs exhalation, generates positive airway pressure, and thereby reduces breathlessness, enhances oxygenation, and expands functional lung capacity. It is particularly beneficial in conditions such as chronic obstructive pulmonary disease (COPD), tracheobronchomalacia, excessive dynamic airway collapse (EDAC), bronchiectasis, atelectasis, and acute respiratory distress syndromes, while also serving broader functions like stress reduction, cardiovascular support, and respiratory muscle training. The device is lightweight, portable, and lanyard-supported, allowing continuous availability for daily use and physical activity. Structurally, it is conical, features a primary airflow chamber, a mouth opening, and one or more resistance orifices that regulate exhalation pressure. By maintaining consistent PEP levels (ranging approximately 4-15 cm H2O), the device helps prevent airway collapse, promotes alveolar recruitment, and improves the ventilation-perfusion ratio.
A method of facilitating pulmonary expansion comprising the use of a portable positive expiratory pressure (PEP) device configured to deliver adjustable expiratory backpressure within a range of approximately 4 cm H2O to 15 cm H2O, wherein said expiratory pressure promotes alveolar recruitment, enhances lung expansion, improves pulmonary gas exchange, and oxygenation, the method being applicable to both individuals with normal lung function and patients with conditions associated with reduced alveolar surface area, including but not limited to atelectasis, acute respiratory distress syndrome (ARDS) and hypoxic respiratory failure.
A therapeutic system for the prevention and treatment of atelectasis, comprising a portable PEP device that generates controlled positive airway pressure during exhalation, wherein:
A method of inducing parasympathetic nervous system activity through controlled respiratory maneuvers comprising exhalation against positive expiratory resistance, wherein the PEP device facilitates:
Dependencies are inferred from the claim text.